Esperion Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| WASATCH ADVISORS LP | 11/14/2024 | 23.35 M | $38.52 M | 38.45% | 11.98% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 14.26 M | $23.54 M | 100.00% | 7.32% |
| VANGUARD GROUP INC | 11/13/2024 | 13.04 M | $21.52 M | 20.58% | 6.69% |
| BELLEVUE GROUP AG | 11/14/2024 | 9.94 M | $16.41 M | 0.00% | 5.10% |
| TWO SEAS CAPITAL LP | 11/14/2024 | 6.58 M | $10.86 M | 14.80% | 3.38% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 4.33 M | $7.15 M | 4.13% | 2.22% |
| STATE STREET CORP | 11/14/2024 | 3.85 M | $6.36 M | 2.66% | 1.98% |
| MEDITOR GROUP LTD | 10/07/2024 | 3.79 M | $6.26 M | 0.00% | 1.94% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 3.63 M | $5.98 M | -11.04% | 1.86% |
| TWO SIGMA ADVISERS, LP | 11/14/2024 | 3.60 M | $5.94 M | -7.08% | 1.85% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 3.40 M | $5.62 M | -47.75% | 1.75% |
| CENTERBOOK PARTNERS LP | 11/14/2024 | 3.11 M | $5.14 M | 98.32% | 1.60% |
| MARSHALL WACE, LLP | 11/14/2024 | 3.09 M | $5.10 M | -28.14% | 1.59% |
| MORGAN STANLEY | 11/14/2024 | 2.65 M | $4.37 M | -20.51% | 1.36% |
| WOODLINE PARTNERS LP | 11/14/2024 | 2.24 M | $3.70 M | -55.56% | 1.15% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 2.10 M | $3.46 M | -7.64% | 1.08% |
| JPMORGAN CHASE & CO | 12/26/2024 | 2.07 M | $3.41 M | 0.96% | 1.06% |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 11/13/2024 | 1.98 M | $3.26 M | 0.00% | 1.01% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 1.31 M | $2.16 M | 42.76% | 0.67% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 1.12 M | $1.85 M | -3.43% | 0.58% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 11/08/2024 | 1.09 M | $1.80 M | -8.66% | 0.56% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 914,100 | $1.51 M | -35.71% | 0.47% |
| PARKMAN HEALTHCARE PARTNERS LLC | 11/14/2024 | 903,140 | $1.49 M | -21.10% | 0.46% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 756,027 | $1.25 M | 45.68% | 0.39% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 750,784 | $1.24 M | -31.91% | 0.39% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 11/08/2024 | 711,278 | $1.17 M | 71.02% | 0.36% |
| DIAMETRIC CAPITAL, LP | 11/13/2024 | 666,839 | $1.10 M | -10.35% | 0.34% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 602,936 | $994,845 | 66.82% | 0.31% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 554,914 | $915,608 | 0.00% | 0.28% |
| WALLEYE TRADING LLC | 11/14/2024 | 525,200 | $866,580 | 0.00% | 0.27% |
| SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2024 | 518,100 | $854,865 | -38.88% | 0.27% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 431,200 | $711,480 | -14.77% | 0.22% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 425,774 | $702,527 | -25.61% | 0.22% |
| CITADEL ADVISORS LLC | 11/14/2024 | 369,400 | $609,510 | -5.52% | 0.19% |
| CAPTION MANAGEMENT, LLC | 11/14/2024 | 368,800 | $608,520 | 0.00% | 0.19% |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | 11/15/2024 | 367,373 | $606,165 | 100.00% | 0.19% |
| ANSON FUNDS MANAGEMENT LP | 11/15/2024 | 327,110 | $539,732 | 100.00% | 0.17% |
| BARCLAYS PLC | 11/19/2024 | 309,671 | $510,000 | 99.58% | 0.16% |
| PINNACLE ASSOCIATES LTD | 10/25/2024 | 283,255 | $846,932 | 0.70% | 0.15% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 11/12/2024 | 262,134 | $433,000 | 145.62% | 0.13% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 11/08/2024 | 254,265 | $419,537 | 0.00% | 0.13% |
| PARALLEL ADVISORS, LLC | 11/13/2024 | 244,000 | $402,600 | 2.09% | 0.13% |
| RHUMBLINE ADVISERS | 11/12/2024 | 243,090 | $401,092 | -3.55% | 0.12% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 11/14/2024 | 242,847 | $400,698 | -10.35% | 0.12% |
| GRAHAM CAPITAL MANAGEMENT, L.P. | 11/14/2024 | 237,563 | $391,979 | -30.51% | 0.12% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 232,000 | $382,800 | -75.18% | 0.12% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2024 | 229,330 | $378,395 | 100.00% | 0.12% |
| HAP TRADING, LLC | 11/12/2024 | 225,000 | $50,625 | 0.00% | 0.12% |
| JANE STREET GROUP, LLC | 11/15/2024 | 222,786 | $367,597 | -10.20% | 0.11% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 11/14/2024 | 222,482 | $367,095 | 0.00% | 0.11% |
Esperion Therapeutics, Inc.institutional Ownership - FAQ's
During the previous two years, 252 institutional investors and hedge funds held shares of Esperion Therapeutics, Inc.. The most heavily invested institutionals were:
WASATCH ADVISORS LP: 23.35 M
BlackRock Funding, Inc. /DE: 14.26 M
VANGUARD GROUP INC: 13.04 M
Bellevue Group AG: 9.94 M
Two Seas Capital LP: 6.58 M
GEODE CAPITAL MANAGEMENT, LLC: 4.33 M
66.33% of Esperion Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 145.89 M shares in the last 24 months. This purchase volume represents approximately $326.79 M in transactions.